Health Insurance (Section 3C General Medical Services—Cataract) Determination 2017
I, TERESA GORONDI, delegate of the Minister for Health, make this Determination under subsection 3C(1) of the Health Insurance Act 1973.
TERESA GORONDI
A/g Assistant Secretary
Medical Specialist Services Branch
Medical Benefits Division
Department of Health
5. Treatment of relevant services
6. Application of provisions of the general medical services table
Schedule 1 – relevant services
This Determination is the Health Insurance (Section 3C General Medical Services—Cataract) Determination 2017.
This Determination is taken to:
(a) have commenced on 1 May 2017; and
(b) is repealed at the end of 31 December 2017.
This Determination is made under subsection 3C(1) of the Health Insurance Act 1973.
(1) In this Determination:
Act means the Health Insurance Act 1973.
relevant provisions means all provisions, of the Act and regulations made under the Act, and the National Health Act 1953 and regulations made under the National Health Act 1953, relating to medical services, professional services or items.
relevant service means a health service, as defined in subsection 3C(8) of the Act, that is specified in a Schedule.
Schedule means a Schedule to this Determination.
Note: The following terms are defined in subsection 3(1) of the Act:
(2) Unless the contrary intention appears, a reference in this Determination to a provision of the Act or the National Health Act 1953 or regulations made under the Act or under the National Health Act 1953 as applied, adopted or incorporated in relation to specifying a matter is a reference to those provisions as in force from time to time and any other reference to provisions of an Act or regulations is a reference to those provisions as in force from time to time.
For subsection 3C(1) of the Act a relevant service, provided in accordance with this Determination and as a clinically relevant service, is to be treated, for the relevant provisions, as if:
(a) it were both a professional service and a medical service; and
(b) there were an item in the general medical services table that:
(i) related to the service; and
(ii) specified for the service a fee in relation to each State, being the fee specified in the Schedule in relation to the service.
(1) Clause 1.2.4 of the general medical services table shall have effect as if item 42705 were also specified in subclause 1.2.4(1).
(2) Clause 1.2.5 of the general medical services table shall have effect as if item 42705 were also specified in subclause 1.2.5(1).
(3) Clauses 1.2.1 and 2.44.2 of the general medical services table shall have effect as if item 42705 were also specified in the clause.
(4) An item of the general medical services table mentioned in column 1 of an item of the table shall have effect as if the reference to a medical service or item, as appropriate, in column 2 of the table item included a reference to the health service or item that relates to the health service mentioned in column 3 of the table item.
Item | Column 1 Item of the general medical services table | Column 2 Reference to service or item | Column 3 Health service or item that relates to the health service |
1 | 42719 | item 42698, 42702, 42716, 42725 or 42731 | item 42705 |
2 | 42731 | item 42698, 42702, 42719 or 42725 | item 42705 |
3 | 42789 | item 42702 | item 42705 |
4 | 45051 | service listed in Group T8 | health service specified in the Schedule |
5 | 45572 | item in Group T8 | item 42705 |
6 | 51315 | item 42698, 42701, 42702, 42704 or 42707 | item 42705 |
Group T8—Surgical operations | ||
Subgroup 9—Ophthalmology | ||
Item | Service | Fee ($) |
42705 | Lens extraction and insertion of intraocular lens, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye, performed in association with a trans-trabecular drainage device or devices, in a patient diagnosed with open angle glaucoma who is not adequately responsive to topical anti-glaucoma medications or who is intolerant of anti-glaucoma medication (Anaes.) | 760.65 |